KEAP1 and hepatoblastoma: To determine whether sedanolide modulates the KEAP1–NRF2 pathway, we used the human hepatoblastoma cell line HepG2 in which activation of the KEAP1–NRF2 pathway can be monitored by the ARE-dependent transactivation of the luciferase gene [24].